Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Guimard

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of the International AIDS Society|November 14, 2014
Prevalence and risk factors of sleep disturbances in a large HIV-infected adult populationClotilde Allavena, Thomas Guimard, Eric Billaud, et al.
Emerging Infectious Diseases|November 23, 2022
Clinical and Epidemiologic Characteristics and Therapeutic Management of Patients with Vibrio Infections, Bay of Biscay, France, 2001-2019Florence Hoefler, Xavier Pouget-Abadie, Mariam Roncato-Saberan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 21, 2015
Antiphospholipid Antibody Syndrome With Valvular Vegetations in Acute Q FeverMatthieu Million, Franck Thuny, Nathalie Bardin, et al.
The Journal of Antimicrobial Chemotherapy|January 31, 2019
Tolerability of high-dose ceftriaxone in CNS infections: a prospective multicentre cohort studyPaul Le Turnier, Dominique Navas, Denis Garot, et al.
Open Forum Infectious Diseases|November 9, 2023
Effect of Swine Glyco-humanized Polyclonal Neutralizing Antibody on Survival and Respiratory Failure in Patients Hospitalized With Severe COVID-19: A Randomized, Placebo-Controlled TrialBenjamin Gaborit, Bernard Vanhove, Karine Lacombe, et al.
Antimicrobial Agents and Chemotherapy|June 26, 2019
High-Dose Ceftriaxone for Bacterial Meningitis and Optimization of Administration Scheme Based on NomogramMatthieu Grégoire, Eric Dailly, Paul Le Turnier, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 4, 2021
Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trialVincent Dubée, Pierre-Marie Roy, Bruno Vielle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 20, 2022
Impact of Enterococcus faecalis Endocarditis Treatment on Risk of RelapsePierre Danneels, Jean-François Hamel, Léa Picard, et al.
Medicine|October 6, 2020
A strobe multicenter descriptive study of 55 infectious aortitisLouis Journeau, Marine de la Chapelle, Thomas Guimard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 20, 2026
Recombinant vs Standard Influenza Vaccine in Adults With Severe Obesity: A Randomized Clinical TrialPaul Loubet, Sébastien Czernichow, Caroline Giboin, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of the International AIDS Society|November 14, 2014
Prevalence and risk factors of sleep disturbances in a large HIV-infected adult populationClotilde Allavena, Thomas Guimard, Eric Billaud, et al.
Emerging Infectious Diseases|November 23, 2022
Clinical and Epidemiologic Characteristics and Therapeutic Management of Patients with Vibrio Infections, Bay of Biscay, France, 2001-2019Florence Hoefler, Xavier Pouget-Abadie, Mariam Roncato-Saberan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 21, 2015
Antiphospholipid Antibody Syndrome With Valvular Vegetations in Acute Q FeverMatthieu Million, Franck Thuny, Nathalie Bardin, et al.
The Journal of Antimicrobial Chemotherapy|January 31, 2019
Tolerability of high-dose ceftriaxone in CNS infections: a prospective multicentre cohort studyPaul Le Turnier, Dominique Navas, Denis Garot, et al.
Open Forum Infectious Diseases|November 9, 2023
Effect of Swine Glyco-humanized Polyclonal Neutralizing Antibody on Survival and Respiratory Failure in Patients Hospitalized With Severe COVID-19: A Randomized, Placebo-Controlled TrialBenjamin Gaborit, Bernard Vanhove, Karine Lacombe, et al.
Antimicrobial Agents and Chemotherapy|June 26, 2019
High-Dose Ceftriaxone for Bacterial Meningitis and Optimization of Administration Scheme Based on NomogramMatthieu Grégoire, Eric Dailly, Paul Le Turnier, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 4, 2021
Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trialVincent Dubée, Pierre-Marie Roy, Bruno Vielle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 20, 2022
Impact of Enterococcus faecalis Endocarditis Treatment on Risk of RelapsePierre Danneels, Jean-François Hamel, Léa Picard, et al.
Medicine|October 6, 2020
A strobe multicenter descriptive study of 55 infectious aortitisLouis Journeau, Marine de la Chapelle, Thomas Guimard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 20, 2026
Recombinant vs Standard Influenza Vaccine in Adults With Severe Obesity: A Randomized Clinical TrialPaul Loubet, Sébastien Czernichow, Caroline Giboin, et al.
Pageof 3